|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000213923 |
Summary for CSNK1E |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000213923 | Gene symbol | CSNK1E |
| Gene name | casein kinase 1 epsilon | |
| HGNC | 2453 | |
| Entrez ID | 1454 | |
| Gene type | protein_coding | |
| Synonyms | CSNK1E|HCKIE|CKIE|CKIepsilon | |
| UniProtAcc | P49674 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| ENSG00000213923 | CSNK1E | DB06195 | Seliciclib | SmallMoleculeDrug |
| ENSG00000213923 | CSNK1E | DB14989 | Umbralisib | SmallMoleculeDrug |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for CSNK1E |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CSNK1E | 6.92e+03 | 1.05e+00 | 1.50e-01 | 7.02e+00 | 2.19e-12 | 3.23e-11 | KICH |
| CSNK1E | 4.34e+03 | 1.63e+00 | 2.54e-01 | 6.43e+00 | 1.25e-10 | 2.11e-09 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| CSNK1E | 3.91e+03 | 1.09e+00 | 1.05e-01 | 1.04e+01 | 2.76e-25 | 8.52e-24 | COAD |
| CSNK1E | 4.76e+03 | 1.12e+00 | 2.13e-01 | 5.29e+00 | 1.23e-07 | 1.39e-06 | READ |
Top |
Sex-biased somatic mutation for CSNK1E |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for CSNK1E |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for CSNK1E |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| ESCA | exon_skip_369449 | 2.95e-01 | 1.73e-01 | 2.34e+00 | 1.94e-02 | 3.20e-02 | 1.22e-01 |
| CHOL | exon_skip_369449 | 3.49e-01 | 6.88e-02 | 3.19e+00 | 1.41e-03 | 1.03e-02 | 2.80e-01 |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| BRCA | exon_skip_369449 | 2.01e-01 | 7.41e-02 | 1.08e+01 | 2.00e-27 | 8.72e-26 | 1.27e-01 |
Top |
RNA A-to-I editing events in TCGA for CSNK1E |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| LUAD | CSNK1E-001 | chr22_38354806_- | 6.48e-01 | 3.89e-01 | 2.83e+00 | 4.62e-03 | 2.30e-02 | 2.58e-01 |
| LUSC | CSNK1E-001 | chr22_38355691_- | 3.97e-01 | 5.61e-01 | -2.74e+00 | 6.08e-03 | 4.91e-02 | -1.64e-01 |
| STAD | CSNK1E-001 | chr22_38361284_- | 3.34e-01 | 2.18e-01 | 2.74e+00 | 6.08e-03 | 4.96e-02 | 1.16e-01 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for CSNK1E |
| TFs related to CSNK1E. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| CSNK1E related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for CSNK1E |
| RBPs related to ES in CSNK1E. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | ANKHD1 | exon_skip_369450 | 1.44e+01 | 6.17e-04 | 1.51e+01 | 9.99e-01 | Female-biased |
| ACC | HNRNPA2B1 | exon_skip_369459 | 1.24e+01 | 9.89e-01 | 1.20e+01 | 1.00e-02 | Male-biased |
| UVM | HNRNPA2B1 | exon_skip_369459 | 1.23e+01 | 9.98e-01 | 1.19e+01 | 1.73e-03 | Male-biased |
| LIHC | ANKHD1 | exon_skip_369450 | 1.52e+01 | 2.84e-03 | 1.57e+01 | 9.97e-01 | Female-biased |
| DLBC | HNRNPA2B1 | exon_skip_369459 | 1.20e+01 | 1.21e-03 | 1.26e+01 | 9.98e-01 | Female-biased |
| KIRP | ANKHD1 | exon_skip_369450 | 1.51e+01 | 1.00e+00 | 1.44e+01 | 1.80e-04 | Male-biased |
| BRCA | ANKHD1 | exon_skip_369450 | 1.49e+01 | 9.87e-01 | 1.44e+01 | 1.26e-02 | Male-biased |
| ESCA | PCBP2 | exon_skip_369449 | 7.00e+00 | 9.86e-01 | 6.14e+00 | 7.40e-04 | Male-biased |
| READ | ANKHD1 | exon_skip_369450 | 1.42e+01 | 2.72e-04 | 1.49e+01 | 1.00e+00 | Female-biased |
| READ | FMR1 | exon_skip_369457 | 8.29e+00 | 4.31e-03 | 8.69e+00 | 9.90e-01 | Female-biased |
| PCPG | ANKHD1 | exon_skip_369450 | 1.47e+01 | 9.99e-01 | 1.41e+01 | 6.30e-04 | Male-biased |
| MESO | HNRNPA2B1 | exon_skip_369459 | 1.19e+01 | 9.50e-04 | 1.25e+01 | 9.99e-01 | Female-biased |
| MESO | PCBP2 | exon_skip_369449 | 6.08e+00 | 1.70e-03 | 6.61e+00 | 9.81e-01 | Female-biased |
| PAAD | ANKHD1 | exon_skip_369450 | 1.41e+01 | 4.65e-04 | 1.47e+01 | 9.99e-01 | Female-biased |
| KIRC | ANKHD1 | exon_skip_369450 | 1.42e+01 | 7.83e-04 | 1.48e+01 | 9.99e-01 | Female-biased |
| KIRC | FMR1 | exon_skip_369457 | 8.67e+00 | 9.91e-01 | 8.28e+00 | 3.53e-03 | Male-biased |
| SARC | ANKHD1 | exon_skip_369450 | 1.49e+01 | 9.98e-01 | 1.43e+01 | 1.98e-03 | Male-biased |
| CSNK1E related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs117488083 | chr22:32353755:G:A | - | 0.247679455575969 | 0.0079745511707285 | BLCA | Female-baised eQTL |
| rs76095964 | chr22:32354659:G:A | - | 0.247679455575969 | 0.0079745511707285 | BLCA | Female-baised eQTL |
| rs56150811 | chr22:32359110:C:A | - | 0.247679455575969 | 0.0079745511707285 | BLCA | Female-baised eQTL |
| rs55744002 | chr22:32360983:G:A | - | 0.247679455575969 | 0.0079745511707285 | BLCA | Female-baised eQTL |
| rs79038758 | chr22:32361819:G:A | - | 0.247679455575969 | 0.0079745511707285 | BLCA | Female-baised eQTL |
| rs73166368 | chr22:32362602:T:C | - | 0.247679455575969 | 0.0079745511707285 | BLCA | Female-baised eQTL |
| rs73166369 | chr22:32363812:T:A | - | 0.247679455575969 | 0.0079745511707285 | BLCA | Female-baised eQTL |
| rs77496665 | chr22:32352282:G:C | - | 0.247055600791603 | 0.0083646969015042 | BLCA | Female-baised eQTL |
| rs73166401 | chr22:32383980:A:C | - | 0.206826910868376 | 0.0449244616109098 | BLCA | Female-baised eQTL |
| rs57570397 | chr22:32384253:C:T | - | 0.206826910868376 | 0.0449244616109098 | BLCA | Female-baised eQTL |
| rs41282595 | chr22:32386167:G:A | - | 0.206826910868376 | 0.0449244616109098 | BLCA | Female-baised eQTL |
| rs56101849 | chr22:32394985:G:A | - | 0.206826910868376 | 0.0449244616109098 | BLCA | Female-baised eQTL |
| rs76956700 | chr22:32401488:A:G | - | 0.206826910868376 | 0.0449244616109098 | BLCA | Female-baised eQTL |
| rs41304681 | chr22:32406616:C:G | - | 0.206826910868376 | 0.0449244616109098 | BLCA | Female-baised eQTL |
| rs113069269 | chr22:32346595:C:T | - | 0.206078268147201 | 0.0471081324751125 | BLCA | Female-baised eQTL |
| rs78179756 | chr22:32350215:C:G | - | 0.206078268147201 | 0.0471081324751125 | BLCA | Female-baised eQTL |
| rs55878163 | chr22:32350349:T:C | - | 0.206078268147201 | 0.0471081324751125 | BLCA | Female-baised eQTL |
| rs1968023 | chr22:31546784:G:A | - | -0.0484209810275258 | 0.00569454794396883 | LUAD | Female-baised eQTL |
| rs9606854 | chr22:31534581:C:T | - | -0.0476394128274516 | 0.00901166379861814 | LUAD | Female-baised eQTL |
| rs5749295 | chr22:31536909:A:T | - | -0.0419978596652393 | 0.0103748147775365 | LUAD | Female-baised eQTL |
| rs9609311 | chr22:31522687:C:T | - | -0.0475959906333218 | 0.0107261030508954 | LUAD | Female-baised eQTL |
| rs5753723 | chr22:31606308:T:C | - | 0.0488788082243508 | 0.0108676070049607 | LUAD | Female-baised eQTL |
| rs12628135 | chr22:37669648:A:G | - | 0.0401126662153757 | 0.0114111486207555 | LUAD | Female-baised eQTL |
| rs9611137 | chr22:39286440:T:C | - | 0.085045733164021 | 0.0126359557978625 | LUAD | Female-baised eQTL |
| rs5749227 | chr22:31185180:A:G | - | 0.0470305582925775 | 0.0146197688896051 | LUAD | Female-baised eQTL |
| rs5749248 | chr22:31287725:C:A | - | 0.0471357034397823 | 0.0166548754647573 | LUAD | Female-baised eQTL |
| rs5749222 | chr22:31160773:C:G | - | 0.0398703892725651 | 0.0168169046198191 | LUAD | Female-baised eQTL |
| rs2413052 | chr22:31387795:T:C | - | -0.0473506416790515 | 0.0182903276180542 | LUAD | Female-baised eQTL |
| rs5997893 | chr22:31160117:A:G | - | 0.0392421138490237 | 0.0199534211252625 | LUAD | Female-baised eQTL |
| rs5753486 | chr22:31162834:A:G | - | 0.0392421138490237 | 0.0199534211252625 | LUAD | Female-baised eQTL |
| rs8135417 | chr22:31163269:G:A | - | 0.0391943505269246 | 0.0201755777511225 | LUAD | Female-baised eQTL |
| rs5753630 | chr22:31465964:A:G | - | -0.0396292543994244 | 0.0204157407079161 | LUAD | Female-baised eQTL |
| rs5997969 | chr22:31394028:T:C | - | 0.0397929334755836 | 0.0206789843487533 | LUAD | Female-baised eQTL |
| rs732857 | chr22:37664843:G:A | - | 0.0386423096081401 | 0.0208193288660192 | LUAD | Female-baised eQTL |
| rs62236669 | chr22:37669330:T:C | - | 0.0384440664200427 | 0.0211217143697058 | LUAD | Female-baised eQTL |
| rs5998058 | chr22:31610422:T:C | - | 0.039292713951291 | 0.0293951782825622 | LUAD | Female-baised eQTL |
| rs9606833 | chr22:31354027:T:C | - | -0.0459423308434654 | 0.0298634036714112 | LUAD | Female-baised eQTL |
| rs5753596 | chr22:31391486:C:T | - | 0.0371051871320434 | 0.0303522882786917 | LUAD | Female-baised eQTL |
| rs1894532 | chr22:37663743:T:C | - | 0.0369811525421157 | 0.0312706279295611 | LUAD | Female-baised eQTL |
| rs28540755 | chr22:29714563:C:T | - | 0.0741248083452005 | 0.0318644421209869 | LUAD | Female-baised eQTL |
| rs8138525 | chr22:31615943:T:C | - | 0.0399005554455141 | 0.0319768124585518 | LUAD | Female-baised eQTL |
| rs5753698 | chr22:31574068:T:G | - | -0.0397034668339214 | 0.031988748478714 | LUAD | Female-baised eQTL |
| rs9609329 | chr22:31570327:A:C | - | -0.0398899084410621 | 0.0325262430151642 | LUAD | Female-baised eQTL |
| rs6001530 | chr22:39296087:C:A | - | 0.0736132755553517 | 0.0326888419854072 | LUAD | Female-baised eQTL |
| rs9611138 | chr22:39298120:G:A | - | 0.0736132755553517 | 0.0326888419854072 | LUAD | Female-baised eQTL |
| rs60459126 | chr22:31376568:A:C | - | 0.057174443699312 | 0.0331522420522729 | LUAD | Female-baised eQTL |
| rs9622675 | chr22:37657658:G:T | - | 0.0371687262617651 | 0.0356839689787117 | LUAD | Female-baised eQTL |
| rs9622677 | chr22:37658255:A:C | - | 0.0371611704333909 | 0.035753845279688 | LUAD | Female-baised eQTL |
| rs7287340 | chr22:37658318:C:T | - | 0.0371611704333909 | 0.035753845279688 | LUAD | Female-baised eQTL |
| rs7287358 | chr22:37658396:A:G | - | 0.0371611704333909 | 0.035753845279688 | LUAD | Female-baised eQTL |
| rs28873672 | chr22:31598483:T:G | - | -0.0398169161773162 | 0.0359269896831461 | LUAD | Female-baised eQTL |
| rs28838399 | chr22:31598484:G:A | - | -0.0398169161773162 | 0.0359269896831461 | LUAD | Female-baised eQTL |
| rs5749279 | chr22:31458223:A:G | - | -0.037310214224195 | 0.0369090943372779 | LUAD | Female-baised eQTL |
| rs9622678 | chr22:37661331:A:G | - | 0.0356176158045307 | 0.0375868028339195 | LUAD | Female-baised eQTL |
| rs5997977 | chr22:31406242:T:C | - | -0.0370102947340254 | 0.0413421716016133 | LUAD | Female-baised eQTL |
| rs5749272 | chr22:31434365:T:C | - | -0.0358493117194481 | 0.0423688892808297 | LUAD | Female-baised eQTL |
| rs12485104 | chr22:37662725:T:C | - | 0.0354639538698504 | 0.0436579879544091 | LUAD | Female-baised eQTL |
| rs5749330 | chr22:31759459:T:C | - | 0.0414232026431833 | 0.0446705650998266 | LUAD | Female-baised eQTL |
| rs6518755 | chr22:31763151:T:C | - | 0.0414232026431833 | 0.0446705650998266 | LUAD | Female-baised eQTL |
| rs5997942 | chr22:31286462:C:T | - | 0.0486425898045717 | 0.0488263435813227 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs10427961 | chr22:32617919:T:C | - | 0.100444831599662 | 0.0179434867370523 | KIRC | Male-baised eQTL |
| rs12484719 | chr22:39212075:G:C | - | 0.042180162524605 | 0.0040954364437392 | BLCA | Male-baised eQTL |
| rs5753625 | chr22:31458860:T:C | - | 0.0388459658379708 | 0.00755725514497294 | BLCA | Male-baised eQTL |
| rs2103853 | chr22:31459489:T:C | - | 0.0386791103169547 | 0.00932938343029711 | BLCA | Male-baised eQTL |
| rs5757559 | chr22:39210066:G:A | - | 0.039677346259611 | 0.0138627814338164 | BLCA | Male-baised eQTL |
| rs9613590 | chr22:28301929:C:T | - | 0.0812584309597219 | 0.0190536641052627 | BLCA | Male-baised eQTL |
| rs5753659 | chr22:31497627:A:G | - | 0.0449629525219854 | 0.0208789800841589 | BLCA | Male-baised eQTL |
| rs5750775 | chr22:39211070:C:T | - | 0.0383637909433614 | 0.0212151432824581 | BLCA | Male-baised eQTL |
| rs6001500 | chr22:39211128:A:C | - | 0.0383637909433614 | 0.0212151432824581 | BLCA | Male-baised eQTL |
| rs12106573 | chr22:39211437:T:C | - | 0.0383637909433614 | 0.0212151432824581 | BLCA | Male-baised eQTL |
| rs62228347 | chr22:39212009:T:C | - | 0.0383637909433614 | 0.0212151432824581 | BLCA | Male-baised eQTL |
| rs73424730 | chr22:39211609:A:G | - | 0.0387909532787718 | 0.0219112255760543 | BLCA | Male-baised eQTL |
| rs2050142 | chr22:39209285:T:C | - | 0.0380857648970536 | 0.0234714200991819 | BLCA | Male-baised eQTL |
| rs2050143 | chr22:39209744:A:G | - | 0.0380857648970536 | 0.0234714200991819 | BLCA | Male-baised eQTL |
| rs5757560 | chr22:39210313:T:C | - | 0.0380857648970536 | 0.0234714200991819 | BLCA | Male-baised eQTL |
| rs12162663 | chr22:39210440:A:G | - | 0.0380857648970536 | 0.0234714200991819 | BLCA | Male-baised eQTL |
| rs12162673 | chr22:39210480:A:G | - | 0.0380857648970536 | 0.0234714200991819 | BLCA | Male-baised eQTL |
| rs12162740 | chr22:39210496:T:G | - | 0.0380857648970536 | 0.0234714200991819 | BLCA | Male-baised eQTL |
| rs6001497 | chr22:39210689:C:A | - | 0.0380857648970536 | 0.0234714200991819 | BLCA | Male-baised eQTL |
| rs5750774 | chr22:39210928:G:A | - | 0.0380857648970536 | 0.0234714200991819 | BLCA | Male-baised eQTL |
| rs12484710 | chr22:39212188:C:A | - | 0.0378828783555359 | 0.0237297465519348 | BLCA | Male-baised eQTL |
| rs5757558 | chr22:39209153:T:C | - | 0.0378376071368853 | 0.0255064518429844 | BLCA | Male-baised eQTL |
| rs4820948 | chr22:31169108:A:G | - | -0.0355488563250752 | 0.0266727148509104 | BLCA | Male-baised eQTL |
| rs5997896 | chr22:31170392:A:G | - | -0.0355152478874776 | 0.0275791290691581 | BLCA | Male-baised eQTL |
| rs35269245 | chr22:29236607:C:T | - | 0.0379118171641125 | 0.0288910881211052 | BLCA | Male-baised eQTL |
| rs5752890 | chr22:29246376:G:A | - | 0.0363072164154927 | 0.0320562452931728 | BLCA | Male-baised eQTL |
| rs1003703 | chr22:29232626:G:A | - | 0.0371232297293387 | 0.0349546674167976 | BLCA | Male-baised eQTL |
| rs5753630 | chr22:31465964:A:G | - | 0.0345440332410978 | 0.0413307308393846 | BLCA | Male-baised eQTL |
| rs5750777 | chr22:39216512:G:A | - | 0.036876871775049 | 0.0476076979849054 | BLCA | Male-baised eQTL |
| rs17298479 | chr22:38955461:G:A | - | 0.0438479500226578 | 0.0430845319168671 | LUAD | Male-baised eQTL |
| rs917208 | chr22:31097139:G:A | - | -0.129010286639075 | 0.000390343736592144 | COAD | Male-baised eQTL |
| rs73156787 | chr22:31103769:G:A | - | -0.128105745297171 | 0.000466896222291812 | COAD | Male-baised eQTL |
| rs73156781 | chr22:31084209:C:T | - | -0.114081528091509 | 0.00177841820555005 | COAD | Male-baised eQTL |
| rs4239890 | chr22:38197923:T:C | - | -0.0932607245040474 | 0.0372213716343989 | COAD | Male-baised eQTL |
| rs5756965 | chr22:38197800:T:C | - | -0.0932112677399055 | 0.0372612597641283 | COAD | Male-baised eQTL |
| rs10483152 | chr22:28999981:A:G | - | -0.0607439008328339 | 0.0375329339114349 | COAD | Male-baised eQTL |
| rs4821762 | chr22:38200138:A:C | - | -0.0940883997859026 | 0.0388307564260177 | COAD | Male-baised eQTL |
| rs13053449 | chr22:33066753:G:A | - | 0.064978185315948 | 0.0389053229989591 | COAD | Male-baised eQTL |
| rs13057573 | chr22:33064358:A:C | - | 0.0648055092889257 | 0.0395071755915258 | COAD | Male-baised eQTL |
| rs997567 | chr22:29002010:C:T | - | -0.0601756617288053 | 0.0413497893882356 | COAD | Male-baised eQTL |
| rs9607515 | chr22:38197634:T:A | - | -0.0920762248517396 | 0.0416561320675539 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of CSNK1E |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000213923 | CSNK1E | C0005586 | Bipolar Disorder | 5 | PSYGENET |
| ENSG00000213923 | CSNK1E | C0036341 | Schizophrenia | 2 | PSYGENET |
